91 related articles for article (PubMed ID: 22156467)
1. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
Colanta A; Lin O; Tafe L; Ghossein R; Nafa K; Mitchell T; Ladanyi M; Arcila M
Acta Cytol; 2011; 55(6):563-9. PubMed ID: 22156467
[TBL] [Abstract][Full Text] [Related]
2. Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population.
Liu S; Zhang B; Zhao Y; Chen P; Ji M; Hou P; Shi B
Int J Clin Exp Pathol; 2014; 7(10):6922-8. PubMed ID: 25400776
[TBL] [Abstract][Full Text] [Related]
3. Increased diagnostic sensitivity of palpation-guided thyroid nodule fine-needle aspiration cytology by BRAF V600E-mutation analysis.
Gimm O; Ivansson K; Beka E; Rossitti HM; Garvin S; Söderkvist P
J Pathol Clin Res; 2021 Nov; 7(6):556-564. PubMed ID: 34156770
[TBL] [Abstract][Full Text] [Related]
4. Are there specific cytologic features that can predict BRAF
Mendes JM; Elsheikh TM; Di Marco J; Russell J; Gladkaya T; Nicolas MM; Clapacs E; Bena JF; McAfee JL; Policarpio-Nicolas MLC
Diagn Cytopathol; 2024 Jun; 52(6):295-302. PubMed ID: 38372437
[TBL] [Abstract][Full Text] [Related]
5. Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma.
Zhang X; Zhang X; Du W; Dai L; Luo R; Fang Q; Ge H
Front Endocrinol (Lausanne); 2021; 12():663720. PubMed ID: 33912138
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of FNAC combined with BRAF
Fu J; Yin X; Wang X; Xiao S; Wu X; Duan C; Yu W; Zhang G
Front Endocrinol (Lausanne); 2024; 15():1366724. PubMed ID: 38818506
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAF
Wang X; Xu F; Gao J; Agyekum EA; Sun H; Zhang G; Li X; Xiang H; Hu S; Qian X
J Clin Ultrasound; 2022 Sep; 50(7):942-950. PubMed ID: 35779272
[TBL] [Abstract][Full Text] [Related]
8. Association between macrocalcification and papillary thyroid carcinoma and corresponding valuable diagnostic tool: retrospective study.
Ye M; Wu S; Zhou Q; Wang F; Chen X; Gong X; Wu W
World J Surg Oncol; 2023 May; 21(1):149. PubMed ID: 37194091
[TBL] [Abstract][Full Text] [Related]
9. How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
Dell'Aquila M; Fiorentino V; Martini M; Capodimonti S; Cenci T; Lombardi CP; Raffaelli M; Pontecorvi A; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2021 Oct; 129(10):819-829. PubMed ID: 34076961
[TBL] [Abstract][Full Text] [Related]
10. Annotation-Free Deep Learning-Based Prediction of Thyroid Molecular Cancer Biomarker BRAF (V600E) from Cytological Slides.
Wang CW; Muzakky H; Lee YC; Lin YJ; Chao TK
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768841
[TBL] [Abstract][Full Text] [Related]
11. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract][Full Text] [Related]
12. An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates.
Agrawal T; Xi L; Navarro W; Raffeld M; Patel SB; Roth MJ; Klubo-Gwiezdzinska J; Filie AC
Cytopathology; 2022 May; 33(3):344-349. PubMed ID: 34957617
[TBL] [Abstract][Full Text] [Related]
13. BRAF p.V600E genetic testing based on ultrasound-guided fine-needle biopsy improves the malignancy rate in thyroid surgery: our single-center experience in the past 10 years.
Gong L; Liu Y; Guo X; Wang C; Yan F; Liu J; Hou X; Chen L; Liang K
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4283-4291. PubMed ID: 36070149
[TBL] [Abstract][Full Text] [Related]
14. BRAF
Lu Y; Guo X; Yang M; Wang K; Cao G; Liu Y; Hou X; Chen L; Liang K
Sci Rep; 2023 Oct; 13(1):17129. PubMed ID: 37816788
[TBL] [Abstract][Full Text] [Related]
15. A comparison of DP-TOF Mass Spectroscopy (MS) and Next Generation Sequencing (NGS) methods for detecting molecular mutations in thyroid nodules fine needle aspiration biopsies.
Qian XQ; Agyekum EA; Zhao LL; Yu RL; Li XY; Gu DJ; Yan N; Xu M; Yuan Y; Wang YG; Xin-Ping W; Xu FJ
Front Endocrinol (Lausanne); 2022; 13():928788. PubMed ID: 35992139
[TBL] [Abstract][Full Text] [Related]
16. Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature.
Abutalib MA; Shams A; Tamur S; Khalifa EA; Alnefaie GO; Hawsawi YM
J Med Case Rep; 2023 Dec; 17(1):521. PubMed ID: 38115146
[TBL] [Abstract][Full Text] [Related]
17. Thyroid poorly differentiated carcinoma metastatic to pancreas diagnosed by fine-needle aspiration and demonstrating a novel BRAF fusion.
Ahmadian SS; Jones D; Wakely P; Lott Limbach AA
Cytopathology; 2024 May; 35(3):408-411. PubMed ID: 38361348
[TBL] [Abstract][Full Text] [Related]
18. Unique Molecular Signatures Are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer.
Mollen KP; Shaffer AD; Yip L; Monaco SE; Huyett P; Viswanathan P; Witchel SF; Duvvuri U; Simons JP
Thyroid; 2022 Mar; 32(3):236-244. PubMed ID: 34915753
[No Abstract] [Full Text] [Related]
19. [Application of BRAF in the diagnosis and treatment of thyroid papillary carcinoma].
Zou T; Pan Y; Wang LX
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):629-634. PubMed ID: 34289553
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of whole-exome sequencing in fine-needle aspiration specimens of papillary thyroid microcarcinoma for the identification of novel gene mutations.
Ma L; Gao L; Hu Y; Li X; Liu C; Ji J; Shi X; Pan A; An Y; Luo N; Xia Y; Jiang Y
Clin Genet; 2024 May; 105(5):567-572. PubMed ID: 38326996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
